Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Wellness
Home & Realty
Outdoor Guide
Women
Class of 2023
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
123.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quest Diagnostics
< Previous
1
2
3
4
5
6
Next >
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
3 Pharma Stocks to Buy as Summer COVID Cases Spike
August 23, 2023
Covid cases are on the rise, which might be the booster shot these top pharma stocks for Covid need to regain their trajectory.
Via
InvestorPlace
Exposures
COVID-19
Why Bionano Genomics Stock Tanked Today
August 14, 2023
A CFO departure shines a light on some of the company's recent struggles.
Via
The Motley Fool
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
August 09, 2023
Alzheimer's is a huge problem, and earlier detection could make a big difference.
Via
The Motley Fool
Quest Diagnostics: Dividend Insights
July 05, 2023
Via
Benzinga
Analyst Ratings for Quest Diagnostics
June 29, 2023
Via
Benzinga
The Latest Analyst Ratings for Quest Diagnostics
May 02, 2023
Via
Benzinga
Will Chart Analysts Notice Bad Omen on Quest Diagnostics's Chart
May 02, 2023
Via
Benzinga
Looking for a Bargain? 3 Stocks to Buy That Are Down 10% in 2023
August 02, 2023
Investors looking for bargain stock opportunities in a rapidly-rising market should consider these companies that haven't yet bounced back.
Via
InvestorPlace
Quest Diagnostics Stock Falls on Lower Q2 Revenue and Profits from Lower Productivity Effects, Tightened Outlook
July 26, 2023
Quest Diagnostics Inc (NYSE: DGX) posted Q2 FY23 adjusted EPS of $2.30, down 2.5% Y/Y, beating the consensus of $2.27.
Via
Benzinga
Sustaining Growth Momentum: Quest Diagnostics Continues to Excel and Reports Rising Profits
July 25, 2023
At the end of July 25, 2023, Quest Diagnostics (NYSE:DGX) will reward its shareholders with a dividend payout of $0.71 per share, demonstrating an annualized dividend yield of 2.15%. Remember, only...
Via
Benzinga
Quest Diagnostics, Keysight Technologies And A Stock Up 42% Year To Date On CNBC's 'Final Trades'
July 19, 2023
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes Quest Diagnostics Incorporated (NYSE: DGX) here.
Via
Benzinga
Biden Administration Releases Revised Guidance For Medicare Drug Price Negotiation Amid Industry Lawsuits
June 30, 2023
The Centers for Medicare and Medicaid Services released revised guidance on using its authority with pharmaceutical manufacturers
Via
Benzinga
Quest Diagnostics Q1 Earnings Surpass Expectations; COVID-19 Testing Revenues Slump 80%
April 27, 2023
Via
Benzinga
Analyst Expectations for Quest Diagnostics's Future
April 03, 2023
Via
Benzinga
Analyst Expectations for Quest Diagnostics's Future
March 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
June 29, 2023
Via
Benzinga
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
June 08, 2023
The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a...
Via
Benzinga
Want Growing Passive Income? Consider Buying This Stock
May 24, 2023
This maker of diagnostics tests has delivered 13 years of dividend growth to shareholders.
Via
The Motley Fool
5 Analysts Have This to Say About Quest Diagnostics
January 23, 2023
Via
Benzinga
Analyst Ratings for Quest Diagnostics
January 06, 2023
Via
Benzinga
Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
May 18, 2023
The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in 25 years in 2022, according to a new analysis...
Via
Benzinga
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
May 11, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023
May 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
April 03, 2023
Via
Benzinga
Is This Healthcare Stock a Buy for Dividend Growth Investors?
March 07, 2023
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders.
Via
The Motley Fool
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%
February 15, 2023
These companies may not be finished raising their dividend payments as they both have low payout ratios.
Via
The Motley Fool
Down 40% in 2022, Can Exact Sciences Recover in 2023?
January 23, 2023
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
January 23, 2023
Via
Benzinga
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades'
December 23, 2022
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5%
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.